Cannabis Stock News- Investing in Cannabis and Hemp Stocks

Investorideas.com - Metrospaces (OTC: $MSPC) Seize Upon Real Estate Market Opportunities in the #Cannabis Space; Companies discussed: (NYSE: $ACB) (TSX: $ACB.TO) (NASDAQ: $CRON) (TSX: $CRON.TO) (NYSE: $MO) (CSE: $CROP.C) (OTC: $CRXPF)

Contact Investorideas.com

800-665-0411

Investorideas.com - Metrospaces (OTC: $MSPC) Seize Upon Real Estate Market Opportunities in the #Cannabis Space; Companies discussed: (NYSE: $ACB) (TSX: $ACB.TO) (NASDAQ: $CRON) (TSX: $CRON.TO) (NYSE: $MO) (CSE: $CROP.C) (OTC: $CRXPF)

Metrospaces (OTC: $MSPC) Seize Upon Real Estate Market Opportunities in the #Cannabis Space; Companies discussed: (NYSE: $ACB) (TSX: $ACB.TO) (NASDAQ: $CRON) (TSX: $CRON.TO) (NYSE: $MO) (CSE: $CROP.C) (OTC: $CRXPF)

Point Roberts, WA and Delta, BC - December 12, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering real estate and cannabis stocks releases a snapshot looking at the synergistic opportunity for both sectors.

As the emerging cannabis market explodes with increased legalization across North American markets, Metrospaces, Inc. (OTC:MSPC) Company Executive President, Mr. Oscar Brito, highlights the considerable market opportunities in real estate that many investors may have overlooked.

Listen to the podcast interview with Oscar Brito, Metrospaces, Inc.:

https://www.investorideas.com/Audio/Podcasts/2018/121118-OTCMSPC-OscarBrito-RealEstate.mp3

Metrospaces, Inc. (OTC: $MSPC) President, Oscar Brito, Talks about Real Estate Opportunities in #Cannabis Market

Metrospaces, Inc., a real estate investment firm that invests in operating companies, has made moves in the cannabis space. Brito said the emerging market is growing too fast to ignore and that most of the attention of institutional investors has been focused on aspects other than real estate.

"We're looking around for new opportunities in the marketplace and obviously cannabis is something that is getting to the point where you just can't ignore it any longer," he said. "Everybody jumps into the operating side and that's where the money has really been rushing into. At the same time, we've seen [that] the real estate side has been completely ignored or largely ignored by institutional investors."

The interest of a company like Metrospaces reflects wider trends in the cannabis market that have seen significant market opportunity where legalization has taken effect. An article on Crew Network analyzes the real estate boom that cannabis has helped to instigate in certain parts of the U.S. Pointing out that the sector relies on real estate for cultivation, manufacturing, warehousing and brick-and-mortar stores, the article argues that in cities where it is already legal, cannabis is causing "a spike in warehouse and other industrial property values". The article adds that:

"Data centers, self-storage properties and factories are all being repurposed for cultivation and manufacturing of marijuana. Land values have escalated in states where outside cultivation is permitted."

This is further reflected by the experience in Canada, where a so-called "green rush" is resulting from recreational cannabis legalization on the federal level in October. A piece in the Financial Post cites research from real estate consulting firm Altus Group, indicating that "marijuana-growing facilities have already consumed 8.7 million square feet in the first nine months of 2018," and that "another six-plus-million square feet are in the pipeline". An example of this is Aurora Cannabis Inc.'s (NYSE:ACB) (TSX: ACB) construction of an 800,000 square-foot facility near Edmonton, Alberta, helping to propel that city's commercial real estate sales value to over $1 billion.

More recently it was announced that tobacco company Altria (NYSE:MO) had acquired 45 percent of Cronos Group, Inc. (NasdaqGM:CRON) (TSX: CRON) stock and would convert existing tobacco farmland into cannabis farmland.

However, as with Metrospaces, it isn't only operators that are taking advantage of the market opportunity. Crop Infrastructure Corp. (CSE:CROP) (OTC: CRXPF), a company that constructs, owns and leases real estate solutions to cannabis operators, has massively expanded their portfolio recently. The company announced on December 6 that it had begun a first phase development covering 1,729,000 square feet (40 acres) of outdoor cannabis and 60,000 square feet of greenhouse at its 1,000-acre cannabis farm in Nevada.

Brito said the position was ideal, as it allows companies like Metrospaces to stick with property without having to worry about the frequently troublesome regulation of the cannabis sector itself.

"We like this quite a bit because we can do what we do best – which is invest in real estate – and being on the real estate side lets you cover yourself from the regulatory situation that we have now, where in some places it's illegal and it's still federally prohibited," he said.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article and podcast featuring Metrospaces is a paid for news release on Investorideas.com – third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Investorideas.com - The #CBD Pet Market Opportunity; Canopy (TSX: $WEED.TO), (NYSE: $CGC), CannTrust (TSX: $TRST.TO), EnviroTechnologies (OTC: $ETII), Isodiol (CSE: $ISOL.C) (OTC: $ISOLF)

The #CBD Pet Market Opportunity; Canopy (TSX: $WEED.TO), (NYSE: $CGC), CannTrust (TSX: $TRST.TO), EnviroTechnologies (OTC: $ETII), Isodiol (CSE: $ISOL.C) (OTC: $ISOLF)

Point Roberts, WA and Delta, BC - December 12, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity for the CBD pet market and how companies that are positioned in the cannabis space are adding pet markets to their growing portfolios.

According to the American Pet Products Association (APPA), $69.51 billion was spent on pets in the U.S in 2017 and it's estimated that number will grow to $72.13 billion for 2018. Canadians spend $6.6 billion a year on their pets according to recent numbers.

Looking at how cannabis/CBD plays into the pet market, CTV reported, "In 2017, sales of cannabis products marketed for pets at medical and adult-use cannabis dispensaries was nearly $7 million in California, Colorado, Oregon and Washington, according to BDS Analytics. In Colorado, sales of pet products grew 49 per cent in 2017, versus growth across all product categories at 15 per cent, it said."

Canopy Animal Health, stated as the global leader in cannabinoid science for pets, is a a division of Canopy Health, a wholly owned subsidiary of Canopy Growth Corporation (TSX:WEED), (NYSE:CGC). In August they announced that approval had been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness of cannabidiol ("CBD") to treat anxiety in certain animals.

Continued: The research will be conducted by Canopy Animal Health, a division of Canopy Health which focuses on developing cannabis-based healthcare products for companion animals. The approval comes in the form of a No Objection Letter for the use of a proprietary CBD enriched oil formulation, previously administered in preclinical dosing and safety studies, as a potential therapy for anxiety. The CBD formulation will be produced by Canopy Growth in its GMP-certified production facility in Smiths Falls, Ontario.

From the release: "Our passion to create safe and effective products for animals is driven by the love we share for our pets," commented Marc Wayne, Managing Director, Canopy Health

Innovations. "The use of natural-occurring cannabinoids as a therapy for companion animals is a logical new forefront of medical discovery and the research we are working on at CAH is world leading. These trial approvals mark a significant milestone on the journey of making cannabis-based drugs accepted and recommended by veterinarians."

Trying to set their own paw print in the sector, EnviroTechnologies International, Inc. (OTC: ETII) , just reported that its subsidiary, CBD Health Co., (www.cbdhealthco.com), a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, is progressing in its hemp-based pet supplement products development.

From the news: "Much has been written lately about CBD products and the numerous applications for humans and pets, which has raised consciousness of CBD's therapeutic value. Our CBD products are all cannabidiol-based, which means they are not psychoactive and are safe for pets," said Joe De Leon, CBD's President. "When your pet gets sick, you want the best treatment available and the products we are developing will offer better, more effective and safer medicinal options for pets than traditional pet health products."

Continued: Current research shows that there are several common CBD benefits for dogs, which are, 1) powerful painkiller (the ECS is involved in managing pain and CBD's pain killing properties are well documented); 2) effective anticonvulsant (CBD helps control seizures, tremors, tics and spasms); 3) natural anti-inflammatory; 4) anxiety and stress reducer (anxiety in dogs often results in barking, urination and defecation, chewing and aggression); 5) active antiemetic (reduces nausea and vomiting); and homeostasis promoter (proper functioning of the body).

"Pet owners are committed to their pet's health and well-being and are willing to spend money on pet health products, which make this a multi-billion dollar market, worldwide," said Karren. "We hope to introduce our CBD pet products in 2019 as we believe that our CBD pet products will be superior to those currently offered in this huge industry and will create another profitable channel for our CBD products."

Earlier this year, CannTrust Holdings Inc. (TSX: TRST), one of Canada's leading licensed producers of medical cannabis, announced it entered into a letter of intent with privately-owned company, Grey Wolf Animal Health Inc., to develop groundbreaking cannabis products to support the well-being of pets.

From the news: There are approximately 16 million cats and dogs in Canada with almost two-thirds of Canadian households owning a pet. Canadian pet owners are increasingly treating pets as an extension of their family. With over 350 million pets globally, there is a sizeable market opportunity for cannabis products.

Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) announced in October it will be launching Pawceuticals, a CBD-based product line that naturally aids in restoring a pet's health and improving overall wellness.

While these companies are not solely focused on the pet market, it is another revenue door to open in the CBD market. Investors and industry leaders see further substantial growth for the sector as the US Farm Bill gets closer to reality, as of on Dec. 11th, the Senate voted 87 to 13 to pass the 2018 Farm Bill

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring ETII is a paid for news release on Investorideas.com - third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com

800-665-0411

Investorideas.com - Impact When 2018 Farm Bill Passes; Cronos (NASDAQ: $CRON), Canopy (NYSE: $CGC), Tilray (NASDAQ: $TLRY) Cannabis Sativa (OTC: $CBDS), American Premium (OTC: $HIPH)

Impact When 2018 Farm Bill Passes; Cronos (NASDAQ: $CRON), Canopy (NYSE: $CGC), Tilray (NASDAQ: $TLRY) Cannabis Sativa (OTC: $CBDS), American Premium (OTC: $HIPH)

Point Roberts, WA - December 12, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity in the sector with the expected passing of the US 2018 Farm Bill, possible as early as this week.

Senate Majority Leader Mitch McConnell got the Twitter space buzzing this week when he said,"With today's signature, my provision to legalize industrial hemp is one step closer to reality."

For investors, the big question is what does this mean for the sector when it passes?

Cabot Wealth said last week in an article, What the Farm Bill Means for Cannabis Stocks, "If the Farm Bill passes with hemp legalization intact, it could herald boom times for the CBD industry, with giant retail players like Walgreens and CVS and Walmart becoming the biggest retailers. In fact, Bethany Gomez, the director of research for the cannabis research firm Brightfield Group, said, "Once CBD is fully legalized, we expect that market to absolutely explode, with sales hitting $22 billion by 2022, which is higher than the U.S. cannabis industry."

Tilray, Inc. (NASDAQ: TLRY), talking about being ready to capitalize on the Farm Bill, said on the company's third-quarter earnings call, "Tilray's $500 million in cash, its Nasdaq-listing and its global reach "gives us advantages to very quickly deploy capital in the U.S." if Congress passes the farm bill, which would legalize non-intoxicating cannabidiol derived from hemp."

Making headlines in the sector recently, with news on December 7th that Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) entered into a subscription agreement with tobacco company Altria Group, Inc., Altria agreed to make an approximately C$2.4 billion equity investment in Cronos Group. "This strategic partnership provides Cronos Group with additional financial resources, product development and commercialization capabilities, and deep regulatory expertise to better position the Company to compete, scale and lead the rapidly growing global cannabis industry."

CNN, reporting on the Cronos deal sees this partnership and others benefiting even more with the passing of the Farm Bill, "Congress may finally pass the Farm Bill which would make it legal to produce hemp and potentially open the door for more products containing cannabidiol or CBD."

Benchmark Co. analyst Mike Hickey is betting on Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) to be a winner from the passing of the Farm Bill.

MarketWatch reported "Hickey is expecting the Farm Bill to be approved by year-end, effectively legalizing CBD or cannabidiol, the non-psychoactive ingredient in cannabis, which is used in a variety of medical products. The bill would remove industrial hemp from the government's list of controlled substances and is expected to open the market for rapid expansion."

Continued: "We believe WEED will invest meaningful capital into the U.S. after CBD legalization and leverage the Constellation Brands manufacturing profile to create CBD beverages; we expect a deployment strategy already firmly in place and will provide for near term growth," Hickey wrote.

American Premium Water Corporation (OTC: HIPH) CEO and Interim Chairman Ryan Fishoff said, "The passage of the 2018 Farm Bill will remove any lingering roadblocks to the mainstream acceptance of CBD infused products. Once Hemp is legalized, CBD will not be considered the scarlet letter that it is now in some retail circles. The Company won't have to dance around it with our products by calling it hemp or hemp oil; we can go to market 100% full force with CBD branded products and not have to worry about it inhibiting our sales. This will open the door to big box retailers as well; Amazon, Wal-Mart, Krogers and many other large grocery and convenience store chains will not have hesitation carrying these types of products" Fishoff has been betting on the passage of the Farm Bill, thinking it was a matter of when, not ‘if'. American Premium is focused on harnessing the powers of its "hydro-nano" technology paired with cannabidiol (CBD).

His company just announced that it has entered into a letter of intent with the California-based subsidiary of Growpacker, Inc. (https://www.growpacker.com/) which offers local and international brands key services such as manufacturing, co-packing and distribution for THC & CBD infused products. Another building block was put in place on December 6th with American Premium Water Corporation (OTC: HIPH) reporting it entered into a partnership with Upside Health's product Ouchie, (www.ouchie.com) a pain management app and platform targeting the over 120 million Americans who live with chronic pain. Ouchie's goal is to empower patients to address pain management through various methods, including new treatments like cannabidiol (CBD) and tetrahydrocannabinol (THC). LALPINA CBD will be offered for sale on the platform, as part of the regimens utilizing CBD. Additionally, the product's efficacy and impact will be tracked on the platform to further enhance innovation efforts.

Also looking to grab market share in the CBD space and capitalize on the Farm Bill, Cannabis Sativa, Inc. (OTC: CBDS), the US-based marketer and manufacturer of cannabis & hemp products recently announced that it had secured a patent for a CBD lozenge that helps treat hypertension. This opens up a potentially huge medical opportunity for the Company, as hypertension is the one of the country's biggest ailments, where 7 out of 10 Americans are afflicted with some form of the condition. The global anti-hypertensive drugs market is expected to reach $23.1 billion in size by 2023, according to iHealthcare Analyst Report.

Investors looking to participate in the sector seeing headlines like ‘Hemp legalization included in new farm bill could 'open the floodgates' on nascent industry' are reminded that just like all sectors, there will be winners and losers and due diligence into the products, marketing and strategic partnering is key.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.investorideas.com/Audio/Podcasts/2018/121118-StocksToWatch.mp3

This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com - third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Tuesday, December 11, 2018

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $CLSH) (TSXV: $KHRN.V) (TSXV: $HIP.V)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $CLSH) (TSXV: $KHRN.V) (TSXV: $HIP.V)

Delta, Kelowna, BC - December 11, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $CLSH) (TSXV: $KHRN.V) (TSXV: $HIP.V)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.

Today we're looking at announcements from CLS Holdings USA Inc. (OTCQB: CLSH), Province Brands of Canada, Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF) and Newstrike Brands Ltd. (TSX-V:HIP).

CLS Holdings USA, Inc. announced that the company has obtained a receipt for its final long form prospectus filed with the securities regulatory authorities in the Provinces of Alberta, Manitoba, British Columbia and Ontario and has been granted conditional approval by the Canadian Securities Exchange (the "CSE") to list the common stock in the capital of CLS on the CSE under the ticker symbol "CLSH".

Jeff Binder, Co-Founder, Chairman and CEO of CLS stated, "This is a truly exciting development for the company as it opens CLS to a new and expanded audience of potential shareholders. The company worked extremely hard to obtain this receipt and conditional listing and we are pleased with the outcome."

Province Brands of Canada - the Canadian company developing the world's first beers brewed from the cannabis plant, including non-alcoholic beers which intoxicate using THC and other phytocannabinoids (to be released only when and where the sale of marijuana beverages is permitted by law), and Cambridge Bay Imperial Pilsner, a first-of-its-kind, 7% ABV imperial pilsner brewed from hemp in place of barley (which contains no marijuana and is regulated as an alcohol product) - has signed a Memorandum of Understanding (MOU) for the Caribbean distribution of its products with Ayre Resorts, a new collection of five-star properties opening its first resort in Antigua in 2021.

Under the MOU, Ayre Resorts will have the right to distribute products in jurisdictions where the sale of such products is permitted by all relevant federal and local laws. To the extent that such products are to be imported (as opposed to produced locally by Ayre Resorts under Province Brands' supervision), Ayre Resorts must also demonstrate that export is allowed by the exporting country, and that any such shipment does not violate international law. At present, only Cambridge Bay, Province Brands of Canada's 7% ABV imperial pilsner brewed from hemp in place of barley, would qualify for distribution under these restrictions. Should various Caribbean countries change their laws in the future, Ayre Resorts will also be entitled to distribute Province Brands of Canada's non-alcoholic beers brewed from cannabis which intoxicate using THC and other phytocannabinoids in such countries.

The agreement provides Ayre Resorts with exclusive Caribbean distribution rights to all beverage and food products commercialized or developed by Province Brands of Canada. Ayre's rights under this agreement are not limited to distributing only Province Brands' products in their resorts, but it is the intention of the parties that Province Brands' beers will be prominently featured in all Ayre Resorts properties.

Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, announced that it has signed an endorsement agreement with the highly respected and influential Colombian Association for the Study of Pain (ACED). In endorsing Khiron's patient-focused approach to medical cannabis research and product development, ACED has committed to partnering with the Company on a schedule of patient and physician education programs, modules and events.

Formed as a chapter of the Washington, D.C.-based International Association for the Study of Pain (IASP), ACED is a 300-member interdisciplinary association of physicians whose goal is to study and harmonize all aspects of the research, diagnosis and treatment of pain in Colombia, under the guidelines of the International Association.

Khiron will collaborate with ACED to advance physician education and knowledge about safe and effective pain treatments for patients. This includes exploring opportunities for joint continuing education efforts for doctors, the organization of international congresses, regional and satellite professional development courses, and functional integration with other scientific societies throughout Colombia and Latin America.

Newstrike Brands Ltd. announced that it has completed its previously-announced transaction with Peter Neal and Chris Neal and their company, Neal Brothers Inc. to create a co-branded specialty food products company to develop, market and sell cannabis edibles. Newstrike has also completed its transaction to acquire a minority interest in Neal Brothers, pursuant to a share purchase agreement.

"We're excited to be putting our capabilities together to develop innovative products that enhance both our brands and build long-lasting value in the market," said Jay Wilgar, CEO of Newstrike.

"Adult-use legalized cannabis is just getting started in Canada and we have an ideal partner in Newstrike to develop this opportunity together and unlock the potential for cannabis edibles," said Peter Neal, President and Co-founder, Neal Brothers.

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)

For additional information, please visit: http://www.clsholdingsinc.com

Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Investorideas.com - Ready, Set, Grow - A New Era with 2018 Farm Bill; Cronos (NASDAQ: $CRON), Canopy Growth (NYSE: $CGC), Tilray (NASDAQ: $TLRY) Cannabis Sativa (OTC: $CBDS), American Premium Water (OTC: $HIPH)

Contact Investorideas.com

800-665-0411

Investorideas.com - Ready, Set, Grow - A New Era with 2018 Farm Bill; Cronos (NASDAQ: $CRON), Canopy Growth (NYSE: $CGC), Tilray (NASDAQ: $TLRY) Cannabis Sativa (OTC: $CBDS), American Premium Water (OTC: $HIPH)

Ready, Set, Grow - A New Era with 2018 Farm Bill; Cronos (NASDAQ: $CRON), Canopy Growth (NYSE: $CGC), Tilray (NASDAQ: $TLRY) Cannabis Sativa (OTC: $CBDS), American Premium Water (OTC: $HIPH)

U.S. Senate Majority Leader Mitch McConnell Gets Twitter Buzzing with Tweet on Farm Bill

Point Roberts, WA - December 11, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity in the sector with the expected imminent passing of the US 2018 Farm Bill.

Senate Majority Leader Mitch McConnell got the Twitter space buzzing today when he said,"With today's signature, my provision to legalize industrial hemp is one step closer to reality."

For investors, the big question is what does this mean for the sector when it passes?

Benchmark Co. analyst Mike Hickey is betting on Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) to be a winner from the passing of the Farm Bill.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas